메뉴 건너뛰기




Volumn 52, Issue 6, 2005, Pages 991-996

Bexarotene treatment of late-stage mycosis fungoides and Sézary syndrome: Development of extracutaneous lymphoma in 6 patients

Author keywords

[No Author keywords available]

Indexed keywords

17 ALLYLAMINO 17 DEMETHOXYGELDANAMYCIN; ALPHA2B INTERFERON; BEXAROTENE; CARBOPLATIN; CHLORMETHINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; IFOSFAMIDE; METHOTREXATE; PREDNISONE; PSORALEN; VINCRISTINE;

EID: 19544369825     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.02.055     Document Type: Article
Times cited : (33)

References (7)
  • 1
    • 0034999546 scopus 로고    scopus 로고
    • Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma
    • M. Duvic, A.G. Martin, Y. Kim, E. Olsen, G.S. Wood, and C.A. Crowley for the Members of the Bexarotene Worldwide Study Group Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma Arch Dermatol 137 2001 581 593
    • (2001) Arch Dermatol , vol.137 , pp. 581-593
    • Duvic, M.1    Martin, A.G.2    Kim, Y.3    Olsen, E.4    Wood, G.S.5    Crowley, C.A.6
  • 2
    • 0035340844 scopus 로고    scopus 로고
    • Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: Multinational phase II-III trial results
    • M. Duvic, K. Hymes, P. Heald, D. Breneman, A.G. Martin, and P. Myskowski for Members of the Bexarotene Worldwide Study Group Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results J Clin Oncol 19 2001 2456 2471
    • (2001) J Clin Oncol , vol.19 , pp. 2456-2471
    • Duvic, M.1    Hymes, K.2    Heald, P.3    Breneman, D.4    Martin, A.G.5    Myskowski, P.6
  • 4
    • 13444266494 scopus 로고    scopus 로고
    • Oral bexarotene in a therapy-resistant Sézary syndrome patient: Observations on Sézary cell compartmentalization
    • R.A. el-Azhary, and S.A. Bouwhuis Oral bexarotene in a therapy-resistant Sézary syndrome patient: observations on Sézary cell compartmentalization Int J Dermatol 44 2005 25 28
    • (2005) Int J Dermatol , vol.44 , pp. 25-28
    • El-Azhary, R.A.1    Bouwhuis, S.A.2
  • 5
    • 0002552640 scopus 로고    scopus 로고
    • Cutaneous T-cell lymphoma
    • M.D. Abeloff J.O. Armitage A.S. Lichter J.E. Niederhuber 2nd ed. Churchill Livingstone New York
    • T.M. Habermann, and M.R. Pittelkow Cutaneous T-cell lymphoma M.D. Abeloff J.O. Armitage A.S. Lichter J.E. Niederhuber Clinical oncology 2nd ed. 2000 Churchill Livingstone New York 2720 2747
    • (2000) Clinical Oncology , pp. 2720-2747
    • Habermann, T.M.1    Pittelkow, M.R.2
  • 6
    • 0002719340 scopus 로고
    • Synthetic retinoids in dermatology
    • M.B. Sporn A.B. Roberts D.S. Goodman 2nd ed. Raven Press New York
    • G.L. Peck, and J.J. DiGiovanni Synthetic retinoids in dermatology M.B. Sporn A.B. Roberts D.S. Goodman The retinoids: biology, chemistry, and medicine 2nd ed. 1994 Raven Press New York 631 658
    • (1994) The Retinoids: Biology, Chemistry, and Medicine , pp. 631-658
    • Peck, G.L.1    Digiovanni, J.J.2
  • 7
    • 0037276018 scopus 로고    scopus 로고
    • Bexarotene is a new treatment option for lymphomatoid papulosis
    • R.A. Krathen, S. Ward, and M. Duvic Bexarotene is a new treatment option for lymphomatoid papulosis Dermatology 206 2003 142 147
    • (2003) Dermatology , vol.206 , pp. 142-147
    • Krathen, R.A.1    Ward, S.2    Duvic, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.